Opaleye Management Inc., a 10% owner of Sol-Gel Technologies Ltd. (SLGL), significantly increased its stake in the company. On March 24, 2026, Opaleye purchased 34,665 shares of SLGL at an average price of $72.00 per share, representing a total investment of approximately $2.50 million.
This substantial acquisition follows several other purchases by Opaleye Management Inc. in recent months, indicating a sustained interest in Sol-Gel Technologies. Large insider purchases of this nature are often interpreted by the market as a signal of strong confidence from management regarding the company's future performance and growth potential.
Sol-Gel Technologies Ltd. develops and commercializes transdermal drug delivery systems. The company's technology aims to improve the efficacy and patient experience for various therapeutic applications.